Ignite Creation Date:
2024-05-05 @ 7:07 PM
Last Modification Date:
2024-10-26 @ 9:43 AM
Study NCT ID:
NCT00603434
Status:
COMPLETED
Last Update Posted:
2017-01-12
First Post:
2008-01-16
Brief Title:
Safety Assessment of Potential Interactions Between IV Methamphetamine and Osmotic-Release Methylphenidate OROS-MPH
Sponsor:
University of Cincinnati
Organization:
National Institute on Drug Abuse NIDA
Study Overview
Official Title:
Double-Blind Placebo-Controlled Assessment of Potential Interactions Between Intravenous Methamphetamine and Osmotic-Release Methylphenidate OROS-MPH
Status:
COMPLETED
Status Verified Date:
2009-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a human inpatient clinical pharmacology study to assess potential interactions between intravenous iv methamphetamine infusion and oral osmotic release methylphenidate OROS-MPH The primary objective of this study is to determine the safety of the OROS-MPH concurrent with iv d-methamphetamine infusions of 15 mg and 30 mg Safety outcome measures include cardiovascular responses heart rate HR blood pressure BP and electrocardiograph ECG measurements oral temperature adverse events AEs and clinical laboratory analyses
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None